GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » Loans Receivable

AngioLab (XKRX:251280) Loans Receivable : ₩0.0 Mil (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is AngioLab Loans Receivable?

AngioLab's Loans Receivable for the quarter that ended in Dec. 2023 was ₩0.0 Mil.


AngioLab Loans Receivable Historical Data

The historical data trend for AngioLab's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioLab Loans Receivable Chart

AngioLab Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial - - - - -

AngioLab Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable Get a 7-Day Free Trial - - - - -

AngioLab Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


AngioLab Loans Receivable Related Terms

Thank you for viewing the detailed overview of AngioLab's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


AngioLab (XKRX:251280) Business Description

Traded in Other Exchanges
N/A
Address
65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN
AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.

AngioLab (XKRX:251280) Headlines

No Headlines